Taking stock of the drug industry, from the lab to the medicine chest Sponsored by STAT+: From burst bubble to medical marvel: How lipid nanoparticles became the future of gene therapy By Megan Molteni Adobe The road to developing safe, reliable, mass-producible lipid nanodelivery-bots turned out to be rockier than anyone anticipated. Read More Opinion: Strengthening Gavi is a way forward for global vaccine equity By Nina Schwalbe MICHELE SPATARI/AFP via Getty Images Leveraging its power and influence as an alliance and building on lessons learned, Gavi can get global vaccination back on track. Read More STAT+: The panel was supposed to improve efficiency at the NIH. It hasn't even met for 7 years By Lev Facher Stefani Reynolds-Pool/Getty Images In 2006, Congress created an advisory group meant to regularly critique the NIH. But it hasn’t met for seven years. Read More Sponsor content by Salute To Nurses Salute to Nurses The Boston Globe received over 400 letters for this year's advertorial, Salute to Nurses. The 19 th annual ad section features letters to our city's quiet army of care givers from the people they helped when they needed it most. Read more here. STAT+: Covid shots made Moderna biotech's biggest star, but what now? By Ryan Cross — The Boston Globe Alex Hogan/STAT Moderna is poised to make strides in mRNA vaccines for diseases ranging from flu to HIV to cancer. But scientific and economic hurdles remain. Read More Monday, May 9, 2022 1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser
No comments